Table 3 Risks of second primaries at specific sites

Bladder¹

1.15 (1.05–1.26)

1.32 (1.17–1.48)

1.08 (0.89–1.30)

8

4

4

Blood (leukaemia)²

1.30 (1.17–1.45)

1.91 (1.77–2.05)

1.34 (0.99–1.81)

8

4

4

Blood (myeloma)³

0.83 (0.68–1.02)

1.01 (0.53–1.94)

0.63 (0.48–0.82)

4

1

1

Blood (non-Hodgkin’s lymphoma)

1.04 (0.91–1.19)

1.17 (0.96–1.42)

0.93 (0.65–1.33)

7

2

2

Brain and central nervous system⁴

0.80 (0.71–0.91)

0.95 (0.81–1.11)

0.75 (0.69–0.81)

7

4

3

Cervix uteri⁵

0.88 (0.77–1.00)

0.65 (0.46–0.93)

0.57 (0.23–1.39)

10

2

2

Colorectum⁶

1.12 (0.99–1.27)

1.30 (0.91–1.86)

1.02 (0.87–1.19)

11

5

5

Corpus uteri⁷

1.84 (1.53–2.23)

1.40 (1.12–1.76)

1.75 (1.29–2.37)

16

5

5

Gallbladder⁸

1.13 (0.68–1.87)

0.49 (0.12–1.96)

0.86 (0.63–1.17)

7

1

1

Kidney⁹

1.43 (1.17–1.73)

1.29 (1.15–1.43)

1.35 (0.95–1.92)

11

4

4

Liver¹⁰

0.86 (0.60–1.24)

0.93 (0.71–1.21)

0.56 (0.33–0.96)

7

1

2

Lung¹¹

1.25 (1.03–1.51)

1.65 (1.49–1.82)

0.81 (0.55–1.20)

12

3

3

Oesophagus

1.39 (1.26–1.55)

2.21 (1.89–2.60)

1.20 (1.06–1.37)

9

3

3

Ovary

1.53 (1.35–1.73)

2.24 (1.59–3.13)

1.04 (0.93–1.16)

16

6

6

Pancreas

1.09 (0.93–1.27)

1.35 (1.16–1.57)

0.92 (0.81–1.04)

11

3

4

Skin (melanoma)

1.34 (1.18–1.52)

1.34 (1.23–1.45)

1.25 (1.17–1.35)

7

3

3

Stomach

1.23 (1.12–1.36)

1.90 (1.75–2.06)

1.10 (0.91–1.34)

13

4

4

Thyroid

1.89 (1.49–2.38)

2.06 (1.83–2.31)

1.17 (0.90–1.52)

14

4

3

Vulva¹²

0.92 (0.63–1.35)

–

–

2

0

0